about
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.Optimized adaptive enrichment designs.A decision theoretical modeling for Phase III investments and drug licensing.Approaches to sample size calculation for clinical trials in rare diseases.Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Optimizing Trial Designs for Targeted Therapies
@ast
Optimizing Trial Designs for Targeted Therapies
@en
Optimizing Trial Designs for Targeted Therapies
@nl
type
label
Optimizing Trial Designs for Targeted Therapies
@ast
Optimizing Trial Designs for Targeted Therapies
@en
Optimizing Trial Designs for Targeted Therapies
@nl
prefLabel
Optimizing Trial Designs for Targeted Therapies
@ast
Optimizing Trial Designs for Targeted Therapies
@en
Optimizing Trial Designs for Targeted Therapies
@nl
P2093
P2860
P50
P3181
P1433
P1476
Optimizing Trial Designs for Targeted Therapies
@en
P2093
Carl-Fredrik Burman
Nigel Stallard
Robert A Beckman
Sebastian Jobjörnsson
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0163726
P407
P577
2016-09-29T00:00:00Z
P698
P818
1606.03987